RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @miguelmontejo74: Un estudio epidemiológico es esto. Que se publica en Lancet. El 14% de los que dieron positivo en anticuerpos ahora e…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
For all the nations hoping that we would develop herd immunity...... #dumbasses Full article link: https://t.co/YREg8loyJQ
RT @kikollan: El estudio de prevalencia que hizo España es fantástico. Apenas existen otros a nivel nacional y —lo más importante— con una…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @TheLancet: NEW—First nationwide population-based study presents seroprevalence estimates of antibodies against SARS-CoV-2 at national a…
Spain's SARS-CoV-2 prevalence is just ~5% despite one of Europe's largest #covid19 epidemics, from study today in @TheLancet https://t.co/VANDGYvsEF This is the largest serological survey published to date & should give even further pause to the pursu
RT @ashishkjha: New paper out in @TheLancet about seroprevalence of COVID antibodies in Spain. Here's the paper: https://t.co/ZidtTyKsei…
L' immunité grégaire est irréalisable sans vaccin https://t.co/LxStT99ZH9
RT @ashishkjha: New paper out in @TheLancet about seroprevalence of COVID antibodies in Spain. Here's the paper: https://t.co/ZidtTyKsei…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @ashishkjha: New paper out in @TheLancet about seroprevalence of COVID antibodies in Spain. Here's the paper: https://t.co/ZidtTyKsei…
RT @VHackenbroch: Forget herd immunity. Avoid infections where possible. Practice social distancing. Wear masks. https://t.co/tsVTL8PYl3
RT @kikollan: El estudio de prevalencia que hizo España es fantástico. Apenas existen otros a nivel nacional y —lo más importante— con una…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @pmarsupia: El estudio de seroprevalencia en España acaba de ser publicado en The Lancet, una de las revistas científicas más prestigios…
RT @ashishkjha: New paper out in @TheLancet about seroprevalence of COVID antibodies in Spain. Here's the paper: https://t.co/ZidtTyKsei…
RT @ashishkjha: New paper out in @TheLancet about seroprevalence of COVID antibodies in Spain. Here's the paper: https://t.co/ZidtTyKsei…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @DrEricDing: 2) “Most PCR-confirmed cases have detectable antibodies, but a substantial proportion of people with symptoms compatible wi…
RT @pmarsupia: El estudio de seroprevalencia en España acaba de ser publicado en The Lancet, una de las revistas científicas más prestigios…
RT @ashishkjha: New paper out in @TheLancet about seroprevalence of COVID antibodies in Spain. Here's the paper: https://t.co/ZidtTyKsei…
RT @ashishkjha: New paper out in @TheLancet about seroprevalence of COVID antibodies in Spain. Here's the paper: https://t.co/ZidtTyKsei…
This thread 👍🏽👌🏽 Based on a recent Lancet paper. Herd immunity or lack there of in Spain.
RT @Fatima_mek: تتراكم الأدلة على خطورة إتباع منهج مناعة القطيع - في اسبانيا، حيث عصفت فيها الجائحة وأدت الى قرابة ال٣٠,٠٠٠ ألف وفاة، ٥٪…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
I am a teacher so most of the technical info is over my head. The thing I find interesting as a teacher is the questions the research generates. Look at the replies. Kids, just because you did research and found out about something doesn't mean you are d
RT @devisridhar: My take-away is that antibodies may not be best way to track % of people exposed given they seem to fade after COVID in le…
RT @ashishkjha: New paper out in @TheLancet about seroprevalence of COVID antibodies in Spain. Here's the paper: https://t.co/ZidtTyKsei…
RT @ashishkjha: New paper out in @TheLancet about seroprevalence of COVID antibodies in Spain. Here's the paper: https://t.co/ZidtTyKsei…
RT @_MiguelHernan: Spain's seroprevalence study #ENECOVID is out @TheLancet #SARSCoV2 IgG antibodies: 5% nationwide, 11% in Madrid Lower…
RT @pmarsupia: El estudio de seroprevalencia en España acaba de ser publicado en The Lancet, una de las revistas científicas más prestigios…
RT @ashishkjha: New paper out in @TheLancet about seroprevalence of COVID antibodies in Spain. Here's the paper: https://t.co/ZidtTyKsei…
RT @miguelmontejo74: Un estudio epidemiológico es esto. Que se publica en Lancet. El 14% de los que dieron positivo en anticuerpos ahora e…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
@beighsman @MichaelLoris2 @AndySlater https://t.co/e3WbcuPtne Just citing my source.
"The majority of the Spanish population is seronegative to SARS-CoV-2 infection, even in hotspot areas. These results emphasise the need for maintaining public health measures to avoid a new epidemic wave. " https://t.co/gBzdqqBNpT
RT @astro_duque: Proud of Spain's researchers for carrying out this ambitious nationwide seroprevalence study, published today in the prest…
RT @ashishkjha: New paper out in @TheLancet about seroprevalence of COVID antibodies in Spain. Here's the paper: https://t.co/ZidtTyKsei…
5% de la población española tiene anticuerpos. https://t.co/XLSkeng2nc
Interesante: Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study - The Lancet https://t.co/zvO4RAszYB, see more https://t.co/My7YjLtZaj
RT @ashishkjha: New paper out in @TheLancet about seroprevalence of COVID antibodies in Spain. Here's the paper: https://t.co/ZidtTyKsei…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @astro_duque: Proud of Spain's researchers for carrying out this ambitious nationwide seroprevalence study, published today in the prest…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @kikollan: El estudio de prevalencia que hizo España es fantástico. Apenas existen otros a nivel nacional y —lo más importante— con una…
The news is not good, but really fantastic to have hard evidence based on random testing. The final figures look very similar to the early Chinese figures ~ 1% overall fatality, but confirmed, and also lots of new data (e.g. on loss of smell).
RT @bajoelbillete: Sí, vale, sé que siempre estoy criticando cosas, pero para variar tengo que admitir que el estudio de seroprevalencia qu…
RT @ashishkjha: New paper out in @TheLancet about seroprevalence of COVID antibodies in Spain. Here's the paper: https://t.co/ZidtTyKsei…
RT @EduardToledano: Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study .The Lancet Mar…
RT @ashishkjha: New paper out in @TheLancet about seroprevalence of COVID antibodies in Spain. Here's the paper: https://t.co/ZidtTyKsei…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
Dreams of herd immunity are fading fast. https://t.co/vpmVPrtXDP
33% were asymptomatic !! Wear a mask !!! That's a 1 in 3 chance on having it and unknowingly spreading it ! Wow.
RT @PeterDaszak: Here’s the full paper in @lancet. Biggest serological survey yet published (61K+ people). Only ~5% had COVID antibodies. 9…
RT @kikollan: El estudio de prevalencia que hizo España es fantástico. Apenas existen otros a nivel nacional y —lo más importante— con una…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @ashishkjha: New paper out in @TheLancet about seroprevalence of COVID antibodies in Spain. Here's the paper: https://t.co/ZidtTyKsei…
RT @ashishkjha: New paper out in @TheLancet about seroprevalence of COVID antibodies in Spain. Here's the paper: https://t.co/ZidtTyKsei…
RT @pmarsupia: El estudio de seroprevalencia en España acaba de ser publicado en The Lancet, una de las revistas científicas más prestigios…
RT @kikollan: El estudio de prevalencia que hizo España es fantástico. Apenas existen otros a nivel nacional y —lo más importante— con una…
Basically, we can’t count on herd immunity until we get a vaccine. Wear masks! https://t.co/lfLU2OetLz
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
Another good thread
Spain's large-scale study on the coronavirus indicates just 5% of its population has developed antibodies, strengthening evidence that a so-called herd immunity to Covid-19 is "unachievable," @TheLancet #COVID19 #HerdImmunity #coronavirus https://t.co/ImqA
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @Laurie_Garrett: Hotspots of #COVID19 in Spain have <10% population antibody levels. So: "In light of these findings, any proposed appro…
RT @TheLancet: NEW—First nationwide population-based study presents seroprevalence estimates of antibodies against SARS-CoV-2 at national a…
RT @TheLancet: NEW—First nationwide population-based study presents seroprevalence estimates of antibodies against SARS-CoV-2 at national a…
RT @kikollan: El estudio de prevalencia que hizo España es fantástico. Apenas existen otros a nivel nacional y —lo más importante— con una…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @kikollan: El estudio de prevalencia que hizo España es fantástico. Apenas existen otros a nivel nacional y —lo más importante— con una…
RT @ashishkjha: New paper out in @TheLancet about seroprevalence of COVID antibodies in Spain. Here's the paper: https://t.co/ZidtTyKsei…
RT @TheLancet: NEW—First nationwide population-based study presents seroprevalence estimates of antibodies against SARS-CoV-2 at national a…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
Aún con las debilidades del sesgo de memoria para reportar algunos eventos y el de selección, por la dificultad de localizar a los participantes jóvenes, es un estudio muy interesante: https://t.co/NC1muCOt1h
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @TheLancet: NEW—First nationwide population-based study presents seroprevalence estimates of antibodies against SARS-CoV-2 at national a…
RT @alexandraphelan: Spain's SARS-CoV-2 prevalence is just ~5% despite one of Europe's largest #covid19 epidemics, from study today in @The…
RT @pmarsupia: El estudio de seroprevalencia en España acaba de ser publicado en The Lancet, una de las revistas científicas más prestigios…
RT @ashishkjha: New paper out in @TheLancet about seroprevalence of COVID antibodies in Spain. Here's the paper: https://t.co/ZidtTyKsei…
Ja tenim la publicació del estudi de Prevalencia a ESP Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study https://t.co/RzLwY8iDRR
RT @TheLancet: NEW—First nationwide population-based study presents seroprevalence estimates of antibodies against SARS-CoV-2 at national a…
RT @ashishkjha: New paper out in @TheLancet about seroprevalence of COVID antibodies in Spain. Here's the paper: https://t.co/ZidtTyKsei…
RT @astro_duque: Proud of Spain's researchers for carrying out this ambitious nationwide seroprevalence study, published today in the prest…
@VanessaPeGo @UOL Realmente a matéria é confusa e sem muitos detalhes. Caso tenha interesse, segue o link do estudo e os comparativos. https://t.co/W5nZTDqESN
RT @astro_duque: Proud of Spain's researchers for carrying out this ambitious nationwide seroprevalence study, published today in the prest…
Only 5% of people in this study had protective antibodies. If confirmed and replicated, it basically means that herd immunity isn't going to happen without vaccines. https://t.co/yEEdDgmBjs
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @ashishkjha: New paper out in @TheLancet about seroprevalence of COVID antibodies in Spain. Here's the paper: https://t.co/ZidtTyKsei…
RT @Bonnifacissimo: Me llama la atención que las provincias costeras apenas tienen seroprevalencia y que las centrales sean las que más tie…
RT @astro_duque: Proud of Spain's researchers for carrying out this ambitious nationwide seroprevalence study, published today in the prest…
RT @TheLancet: NEW—First nationwide population-based study presents seroprevalence estimates of antibodies against SARS-CoV-2 at national a…
Apparently, only ~5% in Spain have developed antibodies, which means we won’t get herd immunity any time soon - it’s too novel for humans - without a vaccine :-( https://t.co/Enr0kTE5a4